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Activity Within the Calciﬁed Atherosclerotic
Lesions by Tc 99m HMDP ScintigraphyThe process of active calcium deposition as demon-
strated by radiolabeled ﬂuoride uptake has beenrming Activity Within the Calciﬁed Atherosclerotic Lesions by
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n of the marked area (square).recently proposed to be associated with high-risk
plaques (1). Similarly, the computed tomography
(CT)-veriﬁed spotty calciﬁcation is associated with the
plaques that have resulted in recent acute coronary
events (2). However, although coronary artery calcium
score has been shown to positively correlate with car-
diovascular disease risk, extensive vascular calciﬁca-
tion, probably representing a burnt-out disease, may
be more prominently associated with stable plaques
(3). Because vascular calciﬁcation does not occur in a
degenerative and passive process of calcium deposi-
tion, and may represent an active phenotypic change
associated with bonemineralization (4), bone-forming
activity within the atherosclerotic plaques rather than
calcium volume and/or calcium density scores might
be a better marker for predicting future cardiovascular
events. Indeed, serum levels of alkaline phosphatase,
a marker of osteoblastic activity, have been associated
with all-cause or cardiovascular mortality among sur-
vivors of myocardial infarction and in a general pop-
ulation (5). Similar to the ﬂuoride imaging of the active
process of calciﬁcation, we measured the osteoblastic
activity within the carotid atherosclerotic plaques
by using a technetium Tc 99m hydroxy-methylene-
diphosphonate (99mTc-HMDP) scintigraphy.
A 72-year-old man with a history of hyperuricemia,
dyslipidemia, and hypertension had a bruit in his
left neck. Although he had no symptoms associated
with brain ischemia, carotid artery ultrasonography
and CT angiography showed the calciﬁed athero-
sclerotic lesions of the left internal carotid artery
(Figure 1A). The peak systolic velocity in the left
internal carotid artery was 255.8 cm/s (normal
range <200 cm/s) in Doppler carotid artery ultraso-
nography, and a left post-bulbar internal carotid artery
stenosis was 85% in a diagnostic angiography. In cor-
egistration of enhanced CT and bone scintigraphy, an
intense accumulation of 99mTc-HMDP was observed
within the calciﬁed carotid atherosclerotic lesions
(Figure 1B). There was no measurable accumulation
of 99mTc-HMDP in other atherosclerotic lesions
without vascular calciﬁcation. Based on the NASCET
(North American Symptomatic Carotid Endarterec-
tomy Trial) guidelines, he was a very high-risk
patient for cerebrovascular disease, and the carotid
endarterectomy was performed. Immunohistochem-
ical analysis revealed that bone-speciﬁc alkaline
phosphatase was abundantly expressed in the excised
calciﬁed lesions of atherosclerosis (Figure 1C).
Because 99mTc-HMDP has a strong afﬁnity for hy-
droxyapatite crystals in the mineral phase of bone,
especially sites of new bone formation, the present
report suggests that bone scintigraphy with
99mTc-HMDP might be a feasible and useful method to
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2009;120:1784–92.Diagnostic Value of Quantitative CMR in
Patients Suspected of Having Myocarditis:
A Question of TimingWith interest we read the article by Radunski et al. (1)
reporting on cardiac magnetic resonance (CMR) using
quantitative tissue parameters in patients suspected
of having severe myocarditis. However, several as-
pects of this study differ from previous studies (2,3)
and therefore require careful discussion.
First, viral clearance usually is completed within
the ﬁrst days after infection during the natural course
of myocarditis, and mean duration of disease activitylasts between 2 and 4 weeks (4). In the present study
(1), median interval between onset of symptoms and
CMR was 2 weeks, indicating that approximately 25%
of the patients underwent CMR after more than 7
weeks (interquartile range: 1 to 7 weeks).
Second, no information is given on what the deﬁ-
nition of severe myocarditis was based on, and no
comparison group of patients with “less severe”
myocarditis is presented. In addition, disease severity
is not listed as an inclusion criterion (1), also sug-
gesting that patient inclusion in the study was retro-
spective and not prospective. Therefore, it remains
unclear to what degree the results were inﬂuenced by
disease severity and by the time interval between
disease onset and date of CMR. All factors cause an
inhomogeneity of the patient population, which may
be responsible for the relatively low diagnostic accu-
racy for native T1 mapping of 69%, compared with 2
previous studies (2,3). In these studies, native T1
mapping yielded a diagnostic accuracy of 91%,
respectively, and showed a superior diagnostic per-
formance compared with single conventional CMR
parameters (Lake Louise Criteria) (2,3).
Third, quantitative T2 relaxation times yielded a
lower diagnostic accuracy compared with edema-
sensitive black-blood T2-weighted ratio (63%
vs. 70%) (1). Here, 2 more factors may have hampered
the diagnostic performance of T2 mapping: 1) the ac-
curacy of the T2 mapping sequence has not been
validated with appropriate phantom studies; and
2) T2 mapping was performed with free breathing,
making it more susceptible to motion artifacts
compared with breath-hold sequences.
Fourth, diagnostic accuracy is reported to be
signiﬁcantly higher compared with classic Lake Louise
Criteria when using extracellular volume (ECV) quan-
tiﬁcation in combination with late gadolinium
enhancement (90% vs. 79%, p ¼ 0.0053) (1). Increased
ECV has also been reported in patients with several
cardiac risk factors, for example, diabetes (5). Inter-
estingly, the diagnostic value of ECV was less favor-
able in another recent study on patients with acute
myocarditis with an area under the curve of only 0.71
(2) compared with 0.86 in this study. Unfortunately,
no detailed information is provided on the distribution
of comorbidities in the study population (1), because
an unequal distribution of comorbidities between pa-
tients and controls might have falsely inﬂuenced the
diagnostic performance to the advantage of ECV.
We believe that in a setting of acute myocardial
injury and inﬂammation, quantitative CMR (using
native T1 and T2 mapping) may improve diagnostic
performance of CMR as reported previously (2,3).
However, carefully deﬁned patient populations with
